2008 American Association of Feline Practitioners' feline retrovirus management guidelines (Q34775753)

4 August 2017

2008 American Association of Feline Practitioners' feline retrovirus management guidelines (English)

1 reference

4 August 2017

Katrin Hartmann

3

0 references

Regina Hofmann-Lehmann

object named as

Regina Hofmann-Lehmann

4

0 references

author name string

Julie Levy

1

1 reference

4 August 2017

Cynda Crawford

2

1 reference

4 August 2017

Susan Little

5

1 reference

4 August 2017

Eliza Sundahl

6

1 reference

4 August 2017

Vicki Thayer

7

1 reference

4 August 2017

2 May 2008

1 reference

Journal of Feline Medicine and Surgery

4 August 2017

1 reference

4 August 2017

10

1 reference

4 August 2017

3

1 reference

4 August 2017

300-316

1 reference

Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Covert vertical transmission of feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

FIV, FeLV, and FIPV: interpretation and misinterpretation of serological test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Rapid detection of feline leukemia virus provirus integration into feline genomic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Effect of primary-stage feline immunodeficiency virus infection on subsequent feline calicivirus vaccination and challenge in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Transmission of human and feline immunodeficiency viruses via reused suture material

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Limited efficacy of an inactivated feline immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Animal immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

The virucidal spectrum of a high concentration alcohol mixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Prevention of the contagious spread of feline leukaemia virus and the development of leukaemia in pet cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline immunodeficiency virus infection: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Treatment of feline leukemia virus-infected cats with paramunity inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Efficacy of an inactivated feline leukemia virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline Leukemia Virus Infection: Age-Related Variation in Response of Cats to Experimental Infection2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Efficacy and safety of a feline immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Detection of transient and persistent feline leukaemia virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline immunodeficiency virus is shed in semen from experimentally and naturally infected cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

How long do nosocomial pathogens persist on inanimate surfaces? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Recovery of feline leukaemia virus from non-viraemic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Immunomodulation therapy for feline leukemia virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Antiviral activity of alcohol for surface disinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline behavior guidelines from the American Association of Feline Practitioners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Duration of the latent state in feline leukaemia virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Transmission of feline leukaemia virus in the milk of a non-viraemic cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Low-dose interferon-alpha treatment for feline immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Pathogenesis of Experimental Feline Leukemia Virus Infection2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Reactivation of latent feline leukaemia virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline leukaemia virus: a review of immunity and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline leukaemia virus and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Resistance of surface-dried virus to common disinfection procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Re-examination of feline leukemia virus: host relationships using real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

No evidence of vertical transmission of naturally acquired feline immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

A longitudinal study of lymphocyte subsets in a cohort of cats naturally-infected with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Population characteristics of feral cats admitted to seven trap-neuter-return programs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Canine and feline blood donor screening for infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2008.03.002

10.1016/J.JFMS.2008.03.002

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference